# Safety and Pharmacokinetics of Single Rising Oral Doses of BI 224436 ZW in Healthy Male Volunteers.

> **NCT02183662** · PHASE1 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 105 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** BI 224436
- **DRUG:** Placebo to BI 224436

## Key facts

- **NCT ID:** NCT02183662
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-11
- **Primary completion:** 2010-03
- **Final completion:** —
- **Target enrollment:** 105 (ACTUAL)
- **Last updated:** 2014-07-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02183662

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02183662, "Safety and Pharmacokinetics of Single Rising Oral Doses of BI 224436 ZW in Healthy Male Volunteers.". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02183662. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*